Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01592019 · ClinicalTrials.gov registry record · Early Phase 1
Clinical Study to Evaluate the Role of Microdialysis for the Comparison of Topical Products
A Early Phase 1 study, sponsored by University of Florida.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 6
- Enrollment target
NCT01592019 is a Early Phase 1 study that has completed, run by University of Florida. The registered enrollment target is 6 participants.
The verdict
NCT01592019, a Early Phase 1 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
The investigators hypothesize that a technique called microdialysis can be used to measure the amount of the drug diclofenac which penetrates (enters) the fatty tissue under the skin. Microdialysis uses a small device called a 'probe' to determine the amount of drug which enters a body tissue. The small device is placed directly in the fatty tissue and samples are taken at specific times. The investigators will determine whether site of application affects the availability of the drug.
Interventions
- DRUG Reference, Patch location thigh, batch 1
- DEVICE Test, Patch location thigh, batch 2
- DRUG Reference, Patch location abdomen, batch 1
- DEVICE Test, Patch location abdomen, batch 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2012-04 |
| Est. Completion | 2012-11 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01592019
The ClinicalTrials.gov registry entry for NCT01592019 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Reference, Patch location thigh, batch 1 is the first listed.
NCT01592019 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01592019 about?
NCT01592019 is a clinical study titled "Clinical Study to Evaluate the Role of Microdialysis for the Comparison of Topical Products". The investigators hypothesize that a technique called microdialysis can be used to measure the amount of the drug diclofenac which penetrates (enters) the fatty tissue under the skin. Microdialysis uses a small device called a 'probe' to determine the amount of drug which enters a body tissue. The s...
What is the current status of trial NCT01592019?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 6 participants. The study started on 2012-04. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01592019?
The interventions under investigation include: Reference, Patch location thigh, batch 1 (DRUG), Test, Patch location thigh, batch 2 (DEVICE), Reference, Patch location abdomen, batch 1 (DRUG), Test, Patch location abdomen, batch 2 (DEVICE).
Who is sponsoring clinical trial NCT01592019?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.